NPPB and hydrops fetalis: Its utility in HF has been recognized as an independent predictor of mortality or the need for transplantation in patients with severe chronic HF [92], as providing prognostic information for patients with acute HF when combined with natriuretic peptides [93], implying that it could be used as a biomarker in conjunction with current clinical testing strategies like BNP and NTPROBNP.